Have you considered or been approached about switching from a biologic to a biosimilar for helping manage your inflammatory arthritis? This video about biosimilars may help you understand more about biologics and biosimilars and to have a conversation with your...
Are you considering talking to your healthcare provider about biosimilars or has your healthcare provider talked to you already about biosimilars? As people who live with arthritis, we put together some questions reviewed by our Medical Advisory Committee that might...
Ontario’s Ministry of Health’s Vaccine Clinical Advisory Group (VCAG) issued recommendations on Exceptions to Extended Dose Intervals for COVID-19 vaccines. CAPA wrote this letter due to concerns about the time delay that the National Advisory Council on Immunization...
CAPA’s Board Member Therese Lane, a patient advocate living with Arthritis and Fibromyalgia for 25 years, presented the results of the CAPA #ArthritisThenNow campaign “ArthritisThenNow: Reflecting on treatment changes in inflammatory arthritis“ at the...
ourbelief The Canadian Arthritis Patient Alliance (CAPA) is Canada’s only volunteer-based arthritis patient organization run by patients for patients. True to its grassroots nature, CAPA is entirely patient-driven, independent, and supports a community of people...
The Canadian Rheumatology Association (CRA), with input from the Canadian Arthritis Patient Alliance (CAPA) has developed a Decision Aid for the COVID-19 Vaccine in Patients with Autoimmune Rheumatic Diseases. This Decision Aid is for an adult of age >18 years...
